Chip Stewart

Broad Institute

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index84

i10-index124

Publications401

Citations64,571

Grants

2 total · 0 active

NIH #5R01AR040926-02

FLUORIDE EFFECTS ON OSTEOBLAST EXTRACELLULAR MATRIX

Amount: $134K
Period: 1990-09-25 → 1995-08-31
PIs: 1
Est. capacity / PI: ~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #1R01AR040926-01

FLUORIDE EFFECTS ON OSTEOBLAST EXTRACELLULAR MATRIX

Amount: $131K
Period: 1990-09-25 → 1995-08-31
PIs: 1
Est. capacity / PI: ~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 46

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance
Genome Medicine · 2026-06-27
Clinical validation of a high-performance somatic exome sequencing assay: from target-enrichment strategy to variant calling
npj Genomic Medicine · 2026-04-10
Abstract 1991: Germline predisposition in The Cancer Genome Atlas (TCGA) whole-genome sequencing datasets.
Cancer Research · 2026-04-03
Abstract 2002: The landscape of X chromosome copy number alterations in cancer.
Cancer Research · 2026-04-03
Abstract 3992: Leveraging Ultima Genomics ppmSeq WGS-cfDNA to accurately detect clonal evolution over sequential blood biopsies
Cancer Research · 2026-04-03
Abstract 5934: Genomic signatures of chromosomal instability from a pan-cancer landscape of haplotype-specific copy-number alterations
Cancer Research · 2026-04-03
Abstract 1977: Whole-genome sequencing of &gt;8,000 TCGA samples reveals diverse and atypical spectra of homologous recombination deficiency in primary human cancers.
Cancer Research · 2026-04-03
Abstract 1990: Pan-cancer PCR-free whole-genome sequencing refines the somatic driver landscape beyond exome sequencing alone.
Cancer Research · 2026-04-03
Abstract 1978: Copy number analysis of regulatory regions reveal recurrent promoter/enhancer somatic copy number alterations across &gt;8,000 TCGA samples.
Cancer Research · 2026-04-03
Abstract 1980: Pan-cancer LINE-1 retrotransposition landscapes in TCGA whole-genome sequences.
Cancer Research · 2026-04-03
Abstract 1986: The pan-cancer landscape of chromosome Y alterations.
Cancer Research · 2026-04-03
Abstract 3247: Origins of structural variant junctional insertions across &gt;8,000 TCGA whole genomes
Cancer Research · 2026-04-03
Abstract 7270: Comprehensive mutation profiling from The Cancer Genome Atlas (TCGA) whole-genome sequencing datasets
Cancer Research · 2026-04-03
Abstract 492: Uncovering therapeutically targetable mutations from The Cancer Genome Atlas (TCGA) whole-genome datasets.
Cancer Research · 2026-04-03
Abstract 1989: Systematic discovery and classification of structural variant drivers across &gt;8,000 TCGA whole genomes.
Cancer Research · 2026-04-03
Abstract 7268: AI-Driven stratification of cancer patients using The Cancer Genome Atlas whole-genome sequencing data
Cancer Research · 2026-04-03
Abstract 7274: Structural variant signature discovery across &gt;8,000 TCGA whole genomes using QuantHDP
Cancer Research · 2026-04-03
Abstract 6881: Fast and cost-effective cloud-based pipelines to analyze cancer sequencing data.
Cancer Research · 2026-04-03
Abstract 2001: Discovery of coding and non-coding driver mutations across &gt;8,000 TCGA whole genomes.
Cancer Research · 2026-04-03
Supplementary Figures and Tables from MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
2025-12-10

Open author page on OpenAlex →